Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

Total article views   HTML views PDF downloads Totals
15,660 Dovepress* 14,595+ 1,606 16,201
PubMed Central* 1,065 346 1,411
Totals 15,660 1,952 17,612
*Since 26 July 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar